Repositioning Candidate Details
| Candidate ID: | R0962 |
| Source ID: | DB06257 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | HE-2200 |
| Synonyms: | beta-Aet |
| Molecular Formula: | C19H30O3 |
| SMILES: | [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C=C2C[C@@H](O)CC[C@]12C |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 2697-85-0 |
| Molecular Weight: | 306.446 |
| DrugBank Indication: | Investigated for use/treatment in adverse effects (chemotherapy), hyperlipidemia, autoimmune diseases, and hepatitis (viral, B). |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|